Publisher
Springer International Publishing
Reference137 articles.
1. Amstutz U, Shear NH, Rieder MJ et al (2014) Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Epilepsia 55:496–506
2. Ayra R, Gulati S (2012) Phenytoin-induced gingival overgrowth. Acta Neurol Scand 125:149–155
3. Bailey DN, Briggs R (2005) Valproic acid binding to human serum and human placenta. Ther Drug Monit 27:375–377
4. Bardy AH, Teramo K, Hiilesmaa VK (1982) Apparent clearances of phenytoin phenobarbitone, primidone and carbamazepine during pregnancy: results of the prospective Helsinski study. In: Janz D, Bossi L, Helge H, Richens A, Schmidt D (eds) Epilepsy, pregnancy, and the child. Raven, New York, pp 141–145
5. Bar-Oz B, Nulman I, Koren G, Ito S (2000) Anticonvulsants and breast feeding. Paediatr Drugs 2:113–126